Market regime: Neutral. Technical breakdown detected. Concerns: Price $2.47 is 33.8% below 150 MA ($3.73); Price $2.47 is 25.4% below 200 MA ($3.31); Price $2.47 is 66.8% from 52-week high (needs <= 25%)
Market regime: Neutral. Technical breakdown detected. Concerns: Price $2.42 is 35.0% below 150 MA ($3.72); Price $2.42 is 26.9% below 200 MA ($3.31); Price $2.42 is 67.4% from 52-week high (needs <= 25%)
Market regime: Neutral. Technical breakdown detected. Concerns: Price $2.36 is 36.6% below 150 MA ($3.72); Price $2.36 is 28.7% below 200 MA ($3.31); Price $2.36 is 68.2% from 52-week high (needs <= 25%)
Market regime: Neutral. Technical breakdown detected. Concerns: Price $2.53 is 31.9% below 150 MA ($3.71); Price $2.53 is 23.5% below 200 MA ($3.31); Price $2.53 is 65.9% from 52-week high (needs <= 25%)
AI Evaluations last 3 months
1 records
Date
Price
Decision
Conf
Model
Rationale
05 Mar 2026
$2.53
SELL
72%
claude-sonnet-4-6
RR is currently held at a near-breakeven entry ($2.54 entry vs. $2.53 price), and the technical evidence overwhelmingly supports exiting the position rather than holding or adding. The stock is below all major moving averages in a confirmed downtrend, today's bounce is on anemic volume with no institutional footprint, and relative strength ranks among the weakest in the market. While the recent EPS trajectory is genuinely improving, the complete absence of revenue growth data prevents confirmation of a sustainable fundamental recovery. With the stop-loss at $2.34 only 7.9% below current prices and the next earnings binary event 47 days away with unknown top-line results, the risk/reward skews unfavorable — the stock needs to overcome $3.31 (SMA200), $3.44 (SMA50), and then $3.71 (SMA150) to rebuild any meaningful bullish structure. The recommended action is to SELL at current levels, preserve capital, and reassess after the next earnings report if revenue data confirms the growth story.
An error has occurred. This application may no longer respond until reloaded.
Reload🗙